FOR RESEARCH AND LABORATORY INVESTIGATION ONLY.

GHK-Cu (Copper Tripeptide-1): Investigational Profile

GHK-Cu is a naturally occurring, copper-complexed tripeptide (Glycyl-L-histidyl-L-lysine) widely studied for its role in cellular regulation, tissue remodeling, and inflammatory response.

Discovery and Background

Isolated from human plasma in 1973 by Dr. Loren Pickart, GHK-Cu was initially identified for its age-dependent concentration; levels are robust in early adulthood (approx. 200 ng/mL) but decline significantly by age 60 (approx. 80 ng/mL). Early in vitro models observed its capacity to restore baseline cellular function in aged hepatic tissue, prompting extensive research into its biological signaling capabilities.

Proposed Mechanisms of Action

Current literature and gene expression profiling suggest GHK-Cu modulates multiple cellular pathways:

• Antioxidant Expression: Hypothesized to activate the Nrf2 pathway, promoting the transcription of endogenous antioxidant genes, including superoxide dismutase (SOD).

• Inflammatory Modulation: Observed to stimulate SIRT1 while suppressing pro-inflammatory signaling cascades such as STAT3, NFκB, and MAPK.

• Fibrosis Attenuation: Preclinical models indicate it downregulates TGF-β1 and Smad2/3 activation, which may mitigate excessive collagen deposition and prevent fibrotic scarring.

  
  

Primary Areas of Research

Investigations into GHK-Cu span several disciplines, focusing primarily on its regenerative and protective properties in experimental models:

• Tissue Repair & Dermatology: Extensively researched for its potential to stimulate collagen, elastin, and keratinocyte proliferation. In vivo wound models (including diabetic profiles) show accelerated contraction, epithelialization, and modulated structural protein remodeling.

• Neuroprotection: Animal studies are investigating its capacity to reduce neuroinflammation, improve neuronal survival following traumatic brain injury, and mitigate markers associated with age-related cognitive decline.

• Pulmonary Function: Explored in models of acute lung injury, COPD, and pulmonary fibrosis for its observed ability to attenuate localized inflammation and tissue scarring.

  
  

Structural Variants: GHK-Cu vs. Pal-GHK

Research applications often utilize specific structural variants based on the intended delivery vector:

• GHK-Cu: The complete, copper-bound complex. Because copper is an essential cofactor for the peptide's biological activity, this highly bioactive form is standard for direct cellular research, injectable models, and localized tissue application.

• Pal-GHK: A lipid-modified variant featuring an attached palmitoyl group. While it lacks the direct copper bond, the lipid tail significantly enhances permeation through the lipid barrier, making it the primary subject of topical cosmetic absorption studies.